-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2012 to Q4 2023.
- Enanta Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was -$7.35M, a 2542% decline year-over-year.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $198M, a 889% increase from 2022.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $20M, a 550% increase from 2021.
- Enanta Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3.08M, a 65.7% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)